Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cimetidine**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.-Reference-Cited by-同舟云学术

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cimetidine**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.

Published:2006-05 Issue:5 Volume:95 Page:974-984
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Jantratid E.,Prakongpan S.,Dressman J.B.,Amidon G.L.,Junginger H.E.,Midha K.K.,Barends D.M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference67 articles.

1. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Verapamil hydrochloride, propranolol hydrochloride, and atenolol;Vogelpoel;J Pharm Sci,2004

2. WHO model list of essential medicines,2003

3. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride;Verbeeck;J Pharm Sci,2005

4. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: Ranitidine hydrochloride;Kortejärvi;J Pharm Sci,2005

5. Biowaiver monographs for immediate release solid oral dosage forms: Ibuprofen;Potthast;J Pharm Sci,2005

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biowaiver as a Bioequivalence Study Option;Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2023-08-01

2. Evaluation of Excipient Risk in BCS Class I and III Biowaivers;The AAPS Journal;2022-01

3. Provisional BCS Classification of the Leading Oral Drugs on the Global Market;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

4. Scientific considerations to move towards biowaiver for biopharmaceutical classification system class III drugs: How modeling and simulation can help;Biopharmaceutics & Drug Disposition;2021-04

5. Current and Future Prospective of a Versatile Moiety: Imidazole;Current Drug Targets;2020-09-18